1
|
Costello RW, Foster JM, Grigg J, Eakin MN, Canonica W, Yunus F, Ryan D. The Seven Stages of Man: The Role of Developmental Stage on Medication Adherence in Respiratory Diseases. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE 2017; 4:813-20. [PMID: 27587315 DOI: 10.1016/j.jaip.2016.04.002] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 02/24/2016] [Revised: 04/03/2016] [Accepted: 04/06/2016] [Indexed: 02/08/2023]
Abstract
The circumstances and drivers of the decision to initiate, implement, or persist with a medication differ for individuals at each developmental stage. For school-age children with asthma, the social environment of their family's cultural beliefs and the influence of peer networks and school policies are strong determinants of medication adherence. The stage of adolescence can be a particularly challenging time because there is a reduction in parental supervision of asthma management as the young person strives to become more autonomous. To illustrate the importance of such factors, adherence interventions in children and young adults with asthma have used peer-based supports and social supports, particularly social media platforms. In older patients, it is internal rather than external factors and age-related decline that pose challenges to medication adherence. Seniors face the challenges of polypharmacy, reduced social support, increased isolation, and loss of cognitive function. Strategies to promote adherence must be tailored to the developmental stage and respective behavioral determinants of the target group. This review considers the different attitudes toward medication and the different adherence behaviors in young and elderly patients with chronic respiratory conditions, specifically asthma and chronic obstructive pulmonary disease. Opportunities to intervene to optimize adherence are suggested.
Collapse
Affiliation(s)
- Richard W Costello
- Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
| | - Juliet M Foster
- Clinical Management Group, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia
| | - Jonathan Grigg
- Blizard Institute, Queen Mary University London, London, United Kingdom
| | - Michelle N Eakin
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Md
| | - Walter Canonica
- Allergy and Respiratory Diseases Clinica, DIMI Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy
| | - Fasail Yunus
- Faculty of Medicine, Department of Pulmonology and Respiratory Medicine, University of Indonesia, Persahabatan Hospital, Rawamangun, Jakarta, Indonesia
| | - Dermot Ryan
- Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom
| | | |
Collapse
|
2
|
Santos DDO, Martins MC, Cipriano SL, Pinto RMC, Cukier A, Stelmach R. Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. J Bras Pneumol 2010; 36:14-22. [PMID: 20209303 DOI: 10.1590/s1806-37132010000100005] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2009] [Accepted: 09/18/2009] [Indexed: 11/21/2022] Open
Abstract
OBJECTIVE To evaluate treatment compliance and use of inhaled medications of patients with asthma receiving complementary pharmaceutical care. METHODS A controlled prospective parallel study involving a study group and a control group. We selected 60 patients with persistent asthma and using metered-dose inhalers (MDIs), dry powder inhalers (DPIs) or both. The patients were evaluated three times over 60 days. Instructions were provided to the patients in the study group at all visits but only at the first visit to those in the control group. The patients using < 80% or > 120% of the total number of prescribed doses were classified as noncompliant. The inhalation technique was quantified by a scoring system. A satisfactory technique was defined as a score higher than 7 (maximum, 9) for MDIs and higher than 4 (maximum, 5) for DPIs. RESULTS The final study sample comprised 28 study group patients and 27 control group patients, of whom 18 (64.3%) and 20 (74.7%), respectively, were considered treatment compliant. From the first to the third visits, there were increases, in the study and control groups, in the median MDI-use score (from 3 [range, 0-5] to 8 [range, 8-9]; p < 0.001; and from 5 [range, 2-6] to 7 [range, 6-8]), as well as in the median DPI-use score (from 3 [range, 2-4] to 5 [range, 4-5] and from 3 [range, 2-4] to 4 [range, 3-5]). CONCLUSIONS The counseling provided by the pharmacist to the patient was important to assist in the implementation of the appropriate inhalation technique, especially for MDI use.
Collapse
Affiliation(s)
- Daiane de Oliveira Santos
- Department of Pharmacy, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil
| | | | | | | | | | | |
Collapse
|
3
|
Hammer SC, Robroeks CMHHT, van Rij C, Heynens J, Droog R, Jöbsis Q, Hendriks HJE, Dompeling E. Actual asthma control in a paediatric outpatient clinic population: do patients perceive their actual level of control? Pediatr Allergy Immunol 2008; 19:626-33. [PMID: 18221469 DOI: 10.1111/j.1399-3038.2007.00705.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Several epidemiological studies described poor asthma control in children. However, the diagnosis of childhood asthma in these studies is uncertain, and asthma control in children of an outpatient clinic population during treatment by a paediatrician is unknown. (1) to investigate the hypothesis that asthma control in a paediatric outpatient clinic population is better than epidemiological surveys suggest; (2) to find possible explanations for suboptimal asthma control. Asthmatic children aged 6-16 years, known for at least 6 months by a paediatrician at the outpatient clinic, were selected. During a normal visit, both the responsible physicians and parent/children completed a standardised questionnaire about asthma symptoms, limitation of daily activities, treatment, asthma attacks and emergency visits. Overall, excellent asthma control of 8.0% in this study was not significantly better than of 5.8% in the European AIR study (Chi-square, p = 0.24). Separate GINA goals like minimal chronic symptoms and no limitation of activities were better met in our study. Good to excellent controlled asthma was perceived by most children/parents (83%), but was less frequently indicated by the paediatrician (73%), or by objective criteria of control (45%) (chi-square, p = 0.0001). The agreement between patient-perceived and doctor assessed control was low, but improved in poorly controlled children. Patients were not able to perceive the difference between 'excellent asthma control' and 'good control' (p = 0.881).Too little children with uncontrolled disease got step-up of their asthma treatment. Although separate GINA goals like 'minimal chronic symptoms' and 'no limitation of activities' were significantly better in our study, overall, asthma control in this outpatient clinic population, treated by a paediatrician, was not significantly better than in the European AIR study. Poorly controlled disease was related to several aspects of asthma management, which are potentially accessible for improvements.
Collapse
Affiliation(s)
- Sanne C Hammer
- Department of Paediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands.
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Ochoa Sangrador C, González de Dios J. [Consistency of clinical practice with the scientific evidence in the management of childhood asthma]. An Pediatr (Barc) 2005; 62:237-47. [PMID: 15737285 DOI: 10.1157/13071838] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
INTRODUCTION There is substantial inconsistency between the evidence available on the management of childhood asthma and its application in practice. OBJECTIVE To evaluate the degree of appropriateness of current management of childhood asthma. MATERIAL AND METHODS We performed a structured review of the articles published on appropriateness in the recent biomedical literature (last 5 years). Methodological analysis and qualitative synthesis were performed. RESULTS Twenty-three articles were identified that reflected the following problems: insufficient documentation on trigger factors, evolution of pulmonary function and symptoms, inadequate guidelines on the treatment of exacerbations, inadequate use of inhaler devices, insufficient use of anti-inflammatory drugs, unjustified heterogeneity in the selection of anti-inflammatory drugs, lack of correlation between severity and level of treatment, lack of written guidelines on customized self-management, unjustified use of antibiotics, and lack of pulmonary function testing devices. CONCLUSIONS The management of childhood asthma should be reviewed since a large number of decisions made in clinical practice are not always based on valid scientific evidence.
Collapse
Affiliation(s)
- C Ochoa Sangrador
- Servicios de Pediatría, Hospital Virgen de la Concha, Zamora, Spain.
| | | |
Collapse
|
5
|
Hederos CA, Janson S, Hedlin G. Group discussions with parents have long-term positive effects on the management of asthma with good cost-benefit. Acta Paediatr 2005; 94:602-8. [PMID: 16188750 DOI: 10.1111/j.1651-2227.2005.tb01946.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
AIM To investigate if an intervention with extra information and support in a group setting to parents of preschool children could improve adherence and clinical outcome. METHODS This is a controlled, prospective study where the parents of 60 newly diagnosed preschool asthmatic children aged 3 mo-6 y were randomized to either a control group or to an intervention that consisted of four group sessions in close connection with the diagnosis. The basic education on asthma and the written treatment plan were the same in both groups. The outcome measures were questionnaires to the parents and classification of the children according to symptoms and medication. The adherence rate and the burden of asthma were calculated with the help of diaries and weighing of the MDIs used between 12 and 18 mo after inclusion. RESULTS The follow-up rate was 85% after 18 mo. The parents' presence in the sessions was around 70%, with no gender difference. The parents' view on adherence issues improved significantly in the intervention group. In the control group, 30% had poor adherence compared to 8% in the intervention group (p=0.015). Both the parents and the paediatricians underestimated the number of children with poor adherence. The children in the intervention group had significantly fewer exacerbation days during the last 6 mo-2.1 compared to 3.9 d/child-although they had lower inhaled steroid doses after 18 mo. An economic calculation showed that the intervention was profitable. CONCLUSION This intervention resulted in an improvement in the parents' view on adherence, in the measured adherence rates and in the clinical outcome.
Collapse
Affiliation(s)
- C-A Hederos
- Barn-ungdomsmedicin mottagningen, Primary Care Research Unit, Karlstad, Sweden.
| | | | | |
Collapse
|
6
|
Abstract
Paediatric asthma has a considerable impact on both society, in terms of healthcare resources, and patients and their families, in terms of impaired quality of life. The principal goals of asthma treatment are to achieve and maintain control of symptoms. Achieving these goals may involve long-term use of appropriate medication in the form of an inhaled corticosteroid (ICS) and a long-acting ss-agonist (LABA). However, many patients with paediatric asthma are not currently achieving symptom control. The main barriers to asthma control are underuse of effective therapies, inappropriate choice of drug delivery devices and a lack of patient or parent/guardian education regarding the disease and its treatment. By addressing and overcoming these barriers to asthma control, the quality of life of patients and their families may be significantly improved.
Collapse
Affiliation(s)
- Sadie Clayton
- University Hospital North Staffordshire, Academic Department of Paediatrics, City General Site, Stoke on Trent, Staffordshire
| |
Collapse
|
7
|
Fiterman J, Mattos W, Cukier A, Pizzichinni M, Silva RFE, Kahan F, Jardim JR, Brancatelli A. Avaliação da eficácia clínica, aceitabilidade e preferência de dois sistemas inalatórios de beclometasona no tratamento da asma: Pulvinal® versus Aeroliser®. J Bras Pneumol 2004. [DOI: 10.1590/s1806-37132004000500003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
INTRODUÇÃO: Apenas metade dos pacientes asmáticos fazem o tratamento prescrito, o que torna a baixa adesão ao tratamento um dos principais problemas no manejo desta enfermidade. É possível que dispositivos inalatórios que combinem o melhoramento tecnológico com a simplicidade e o conforto em sua utilização possam minimizar a baixa adesão ao tratamento. OBJETIVO: Comparar a aceitabilidade e preferência de dois dispositivos inalatórios para a administração de beclometasona: Clenil Pulvinal(P) e Miflasona Aeroliser (A). Secundariamente, avaliar a eficácia e tolerabilidade desses dois sistemas inalatórios, no controle da asma crônica. MÉTODO: Foi realizado um estudo multicêntrico, aberto, comparativo, randomizado, cruzado, de grupos paralelos, em pacientes com asma estável. Foram incluídos 83 pacientes com asma clinicamente estável em uso de 500 a 1000 mg/dia de beclometasona. Após 2 semanas de observação, os pacientes iniciaram aleatoriamente, por 4 semanas, com doses equivalentes de P ou A, imediatamente seguido do outro tratamento em estudo por 4 semanas. RESULTADOS: Em ambos os grupos, P e A, a dispnéia de esforço e o VEF1 melhoraram. Não houve diferença quanto à eficácia clínica ou à freqüência de efeitos colaterais. A aceitabilidade foi considerada boa ou excelente nos dois grupos. O P foi preferido por 50,6% dos pacientes e o A por 39%. Caso o paciente necessitasse continuar a medicação, o P seria escolhido por 54,5% e o A por 37,7%. CONCLUSÃO: A eficácia clínica da beclometasona administrada pelos dois dispositivos inalatórios estudados (P e A) foi semelhante, tendo ambos também igual aceitabilidade.
Collapse
|
8
|
Trocmé N, Vaudre G, Dollfus C, Leverger G. [Factors impacting on antiretroviral therapy compliance in HIV positive adolescents]. Arch Pediatr 2002; 9:1241-7. [PMID: 12536105 DOI: 10.1016/s0929-693x(02)00113-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
UNLABELLED Is poor treatment observance frequently observed in HIV positive adolescent population, due to the adolescent developmental process, their experience of living with HIV, or lack of information on the disease or treatment? METHODS We interviewed the 29 HIV positive adolescents followed up in one pediatric reference center. Confidential interviews were performed according to a standard questionnaire by psychologist and research nurse. RESULTS Seventy-nine percent had stopped at least once a time their treatment who was the major barrier to their sense of freedom behind their adolescence (one-third of them decided to stop it more than one month), although 75% knew the potential consequences and had a good information about their seeks. Fifty-five percent expressed feelings of loneliness or depression, yet 75% consider they had a pleasant life because they had a normal life. In fact, the secret and silence about HIV were the price for this normality. CONCLUSION Being dependent upon a treatment is a major constraint on the lives of HIV positive adolescents. Although they are fully informed, the deliberate interruption of treatment could attest of their expressed need for autonomy and medical prescription have to be careful with this problem.
Collapse
Affiliation(s)
- N Trocmé
- Service d'hématologie et d'oncologie pédiatrique, hôpital Armand-Trousseau, 75571 Paris cedex 12, France.
| | | | | | | |
Collapse
|
9
|
|